TITLE

Role of CD44 in CTL-induced acute liver injury in hepatitis B virus transgenic mice

AUTHOR(S)
Kimura, Kiminori; Nagaki, Masahito; Saio, Masanao; Moriwaki, Hisataka; Kakimi, Kazuhiro
PUB. DATE
March 2009
SOURCE
Journal of Gastroenterology;2009, Vol. 44 Issue 3, p218
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
There are many uncertain points regarding leukocyte movement in the liver, especially interaction between liver sinus endothelial cells (LSECs) and cytotoxic T lymphocytes (CTLs). We examined the role of CD44 in these interactions using the hepatitis model. CTLs were administered to hepatitis B virus transgenic mice (HBVTg) mice and HBVTg × CD44 knockout (KO) mice, and alanine aminotransferase activity (ALT), number of intrahepatic leukocytes, cytokines, and chemokine mRNA level were examined. To determine the number and distribution of CTLs in the liver, 5,6-carboxyfluoroscein succinimidyl ester (CFSE)-labeled CTLs was administered to HBVTg mice with or without CD44. Serum ALT activity increased after 12 h, although it had declined to 4 h in the CD44KO × HBVTg mice after CTL injection. Similarly, the levels of tumor necrosis factor (TNF)-α, interferon (IFN)-γ, and macrophage inflammatory protein (MIP)-2 mRNAs were reduced in 4 h, although the levels were increased after 12 h in the CD44KO × HBVTg mice. The number of apoptotic hepatocytes increased intentionally at 24 h in the CD44KO × HBVTg livers, and this was thought to result from the lower activity of initial nuclear factor kappa B (NF-κB). Although the number of CTLs was lower at 4 h in the CD44KO × HBVTg livers, the difference of intercellular adhesion molecule (ICAM)-1 and CD86 expression on LSECs was not detected. CD44 exerts and important effect on LSECs for CTL migration into the hepatocytes. However, because the CD44-deficient state exacerbated hepatic injury, attention is necessary for hepatitis treatment as CD44 target therapy.
ACCESSION #
36478880

 

Related Articles

  • Kupffer Cells Hasten Resolution of Liver Immunopathology in Mouse Models of Viral Hepatitis. Sitia, Giovanni; Iannacone, Matteo; Aiolfi, Roberto; Isogawa, Masanori; van Rooijen, Nico; Scozzesi, Cristina; Bianchi, Marco E.; von Andrian, Ulrich H.; Chisari, Francis V.; Guidotti, Luca G. // PLoS Pathogens;Jun2011, Vol. 7 Issue 6, Special section p1 

    Kupffer cells (KCs) are widely considered important contributors to liver injury during viral hepatitis due to their pro-inflammatory activity. Herein we utilized hepatitis B virus (HBV)-replication competent transgenic mice and wild-type mice infected with a hepatotropic adenovirus to...

  • Hepatitis B virus transgenic mouse model of chronic liver disease. Larkin, Jonathan; Clayton, Marcy; Sun, Bill; Perchonock, Claire E.; Morgan, Judith L.; Siracusa, Linda D.; Michaels, Frank H.; Feitelson, Mark A. // Nature Medicine;Aug1999, Vol. 5 Issue 8, p907 

    A model for hepatitis B virus-associated chronic liver disease has been made using cloned hepatitis B virus DNA as a transgene in a severe combined immunodeficient host. These mice consistently support virus gene expression and replication. After adoptive transfer of unprimed, syngeneic...

  • Spontaneous Clearance of Chronic Hepatitis C Virus Infection Is Associated With Appearance of Neutralizing Antibodies and Reversal of T-Cell Exhaustion. Raghuraman, Sukanya; Park, Heiyoung; Osburn, William O.; Winkelstein, Emily; Edlin, Brian R.; Rehermann, Barbara // Journal of Infectious Diseases;3/1/2012, Vol. 205 Issue 5, p763 

    Background. Hepatitis C virus (HCV) readily establishes chronic infection with exhaustion of HCV-specific T cells and escape from neutralizing antibodies. Spontaneous recovery from chronic infection is rare and has never to our knowledge been studied immunologically. Methods. We prospectively...

  • Evaluation of Liver Biopsy in Egyptian HBeAg-Negative Chronic Hepatitis B Patients at Initial Presentation: Implications for Therapy. El-Zayadi, Abdel-Rahman; Badran, Hanaa Mostafa; Saied, Ahmed; Shawky, Sherine; Attia, Mohy El-Deen; Zalata, Khaled // American Journal of Gastroenterology (Springer Nature);Apr2009, Vol. 104 Issue 4, p906 

    OBJECTIVES:A subgroup of HBeAg-negative chronic hepatitis B (CHB) patients with alanine aminotransferase (ALT) and/or hepatitis B virus (HBV)-DNA levels below the cutoff values of international guidelines may have significant liver disease and miss the opportunity for early treatment....

  • Expression of CD39 on FoxP3 T cells correlates with progression of HBV infection.  // BMC Immunology;2012, Vol. 13 Issue 1, p17 

    The article presents a study conducted by the authors related to association of CD39+ T cells, tregs with hepatitis B virus (HBV) infection. Analysis of HBV patients was conducted to assess association of the treg with HBV copy number and the liver injury marker alanine aminotransferase (ALT)....

  • HBx Sensitizes Cells to Oxidative Stress-induced Apoptosis by Accelerating the Loss of Mcl-1 Protein via Caspase-3 Cascade. Liang Hu; Lei Chen; Guang Zhen Yang; Liang Li; Han Yong Sun; Yan Xin Chang; Qian Qian Tu; Meng Chao Wu; Hong Yang Wang // Molecular Cancer;2011, Vol. 10 Issue 1, p43 

    Background: Oxidative stress has been implicated in the pathogenesis of a wide spectrum of human diseases, including Hepatitis B virus (HBV)-related liver disease. Hepatitis B virus X protein (HBx) is a key regulator of HBV that exerts pleiotropic activity on cellular functions. Recent studies...

  • Testing times. Jamil, Khaleel; Forgacs, Ian // Update;Jun2007, Vol. 74 Issue 6, p68 

    The article discusses the significance of raised alanine aminotransferase (ALT) level in a 45-year-old man. It is reported that an elevated ALT results from liver cell damage. The commonest causes are alcohol abuse, fatty liver, drugs and viral hepatitis. When ALT remains persistently high,...

  • Prediction of liver histological lesions with biochemical markers in chronic hepatitis B patients in Iran. Alavian, Seyed Moayed; Alavian, Seyed Hoda; Ashayeri, Neda; Babaei, Marziyeh; Daneshbodi, Maryam; Hajibeigi, Bashir // Gastroenterology & Hepatology from Bed to Bench;Apr2010, Vol. 3 Issue 2, p71 

    Aim: In the current study, we aimed at identifying independent laboratory parameter to predict liver damage. Background: Although liver biopsy is frequently recommended in assessing disease severity and selecting antiviral treatment candidates, it has several limitations. Patients and methods: A...

  • Entecavir Treatment of Chronic Hepatitis D. Kabaçam, Gökhan; Önder, F. Oğuz; Yakut, Mustafa; Seven, Gülseren; Karatayli, Senem C.; Karatayli, Ersin; Savaş, Berna; Idilman, Ramazan; Bozdayi, A. Mithat; Yurdaydin, Cihan // Clinical Infectious Diseases;Sep2012, Vol. 55 Issue 5, p645 

    In this retrospective study, 1-year entecavir treatment of chronic delta hepatitis was ineffective. However, 3 of 13 patients showed a virologic response, which may be linked to shift of the dominant virus or, alternatively, to immune-mediated viral clearance.Background. Hepatitis D virus (HDV)...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics